Unichem Laboratories has received final USFDA approval for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US market. The approved product is therapeutically equivalent to Feldene Capsules 10mg and 20mg of Pfizer Inc. Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA).
The company will produce the drug from its Goa and Roha API plant.
Company Profile : Unichem Laboratories Ltd
Leave a Reply